Macro Group Pharmaceutical S.A.E. (MCRO) Revenue
Revenue
EGP 526.01M
Fiscal year 2023
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2023 | 526.01M | -27.91% |
| 2022 | 729.61M | 22.78% |
| 2021 | 594.26M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.